VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener

Utah Medical Products, Inc. (UTMD) Total Return Calculator with Dividends Reinvested

Utah Medical Products, Inc.

Popular:

The total return for Utah Medical Products, Inc. (UTMD) stock is +23.55% over the past 12 months. So far it's up 16.30% this year. The 5-year total return is -18.16%, meaning $10,000 invested in UTMD stock 5 years ago would be worth $8,184 today. Total return includes price appreciation plus reinvesting any dividends paid out.

If you invested $10,000 in UTMD 1 year ago, it would be worth $12,393 today — you'd have gained $2,393 with dividends reinvested.

With Dividends Reinvested$12,393+23.93%

Price Only (No DRIP)$12,140+21.40%

Dividend Boost+$2524 payments · +2.52% extra

Period2025-05-08 → 2026-05-07

Price

Total Return (DRIP)

Dividends

S&P 500

If You Invested $10,000 in UTMD

1Y$12,355+$2,355 (+23.5%)23.5% CAGR

3Y$7,375-$2,625 (-26.2%)-9.7% CAGR

5Y$8,184-$1,816 (-18.2%)-3.9% CAGR

10Y$11,906+$1,906 (+19.1%)1.8% CAGR

15Y$30,316+$20,316 (+203.2%)7.7% CAGR

20Y$28,367+$18,367 (+183.7%)5.4% CAGR

30Y$57,539+$47,539 (+475.4%)6.0% CAGR

Dividend Reinvestment History (4)▲ Hide

Ex-Date	Dividend	Reinvest Price	Shares Added
2025-06-16	$0.30	$55.06	+0.005539
2025-09-17	$0.30	$61.82	+0.004961
2025-12-16	$0.31	$58.43	+0.005361
2026-03-17	$0.31	$64.05	+0.004917

Loading UTMD total return...

As of 2026-05-08

Returns at a Glance

Period	Total Return	CAGR	Price Only	Div. Contrib.	$10K →
YTD	+16.30%	—	+15.75%	+0.55 pp	$11,630
1Y	+23.55%	23.55%	+21.27%	+2.28 pp	$12,355
3Y	-26.25%	-9.65%	-30.13%	+3.88 pp	$7,375
5Y	-18.16%	-3.93%	-26.74%	+8.58 pp	$8,184
10Y	+19.06%	1.76%	-0.82%	+19.88 pp	$11,906
15Y	+203.16%	7.67%	+137.56%	+65.60 pp	$30,316
20Y	+183.67%	5.35%	+109.21%	+74.46 pp	$28,367
30Y	+475.39%	6.01%	+318.42%	+156.97 pp	$57,539

Risk & Highlights

Best Year+104.44%1995

Worst Year-50.04%1997

Max Drawdown-15.77%2025-10-02 → 2025-11-20 · Recovered 2026-02-10

Annual Returns

Year	Total Return	Price Return	Div.	S&P 500	vs S&P
2026YTD	+18.44%	+17.89%	+0.5pp	+0.41%	+18.0pp
2025	-6.79%	-8.79%	+2.0pp	+16.64%	-23.4pp
2024	-24.92%	-26.37%	+1.4pp	+24.00%	-48.9pp
2023	-12.64%	-13.85%	+1.2pp	+24.81%	-37.5pp
2022	+4.72%	+3.52%	+1.2pp	-19.95%	+24.7pp

UTMD underperformed the S&P 500 by 6.82pp over the past year (+23.55% vs +30.37%).

Loading summary...

UTMD Peers' Total Return

Accurate peer set · 10 comparable names

Name	Mkt Cap	30D Rtn	YTD Total Rtn	1Y Total Rtn	Div Contrib	3Y Total Rtn	5Y Total Rtn	10Y Total Rtn
UTMDUtah Medical Products, Inc.	$210M	+3.0%	+16.3%	+23.5%	+2.3pp	-26.2%	-18.2%	+19.1%
NVCRNovoCure Limited	$1.9B	+62.6%	+28.3%	+1.1%	—	-75.7%	-91.3%	+30.3%
MMSIMerit Medical Systems, Inc.	$3.7B	-7.5%	-27.9%	-33.8%	—	-26.5%	-3.6%	+214.6%
LMATLeMaitre Vascular, Inc.	$2.5B	-2.2%	+34.9%	+33.3%	+1.0pp	+65.2%	+118.2%	+608.6%
ANGOAngioDynamics, Inc.	$469M	+16.2%	-11.1%	+28.5%	—	+25.8%	-53.3%	-9.2%
HOLXHologic, Inc.	$17.0B	+0.0%	+1.9%	+37.1%	—	-8.5%	+15.8%	+124.3%
TNDMTandem Diabetes Care, Inc.	$1.3B	+1.0%	-14.3%	-17.0%	—	-44.8%	-78.0%	-75.4%
NTRANatera, Inc.	$31.2B	+5.0%	-3.9%	+37.3%	—	+314.0%	+115.9%	+2089.4%
INMDInMode Ltd.	$882M	+2.0%	-5.9%	-2.1%	—	-60.2%	-63.9%	+105.0%
COOThe Cooper Companies, Inc.	$12.0B	-12.3%	-24.7%	-24.8%	—	-36.7%	-39.5%	+57.9%
BDXBecton, Dickinson and Company	$55.5B	-1.1%	+0.7%	+51.8%	+3.4pp	+5.0%	+16.9%	+80.2%

Compare:UTMD vs NVCR UTMD vs MMSI UTMD vs LMAT UTMD vs NVCR vs MMSI

About UTMD Dividend Returns

Utah Medical Products, Inc. (UTMD) is a dividend-paying stock. When dividends are reinvested through a DRIP (Dividend Reinvestment Plan), they purchase additional shares, which then generate their own dividends—creating a compounding effect that can significantly boost long-term returns.

How We Calculate Total Return

Our total return calculator simulates dividend reinvestment (DRIP) by assuming each dividend payment is used to purchase additional shares at the closing price on the ex-dividend date. This methodology provides an accurate representation of how a dividend reinvestment plan would perform.

Frequently Asked Questions

Q1What is the total return of UTMD over the past year?

Utah Medical Products, Inc. (UTMD) delivered a total return of 23.55% over the past year when dividends are reinvested. The price-only return was 21.27%, meaning dividends contributed an additional 2.28 percentage points to total returns.

Q2How much would $10,000 invested in UTMD be worth today?

A $10,000 investment in Utah Medical Products, Inc. one year ago would be worth $12,355 today with dividends reinvested (DRIP). Without reinvesting dividends, the same investment would be worth $12,127. Dividend reinvestment added $228 to the portfolio value.

Q3Does UTMD pay dividends?

Yes, Utah Medical Products, Inc. (UTMD) pays dividends. In the last year, UTMD paid approximately $1.23 per share in dividends (1.88% yield). Reinvesting these dividends through a DRIP can significantly boost long-term returns — over 20+ years, dividend compounding can account for 30–50% of total returns for dividend-paying stocks.

Q4Did UTMD beat the S&P 500?

No, Utah Medical Products, Inc. (UTMD) underperformed the S&P 500 by 6.82 percentage points over the past year. UTMD delivered a total return of 23.55%, compared to the S&P 500's 30.37%. This means a passive S&P 500 index fund outperformed UTMD by 6.82pp during this period.

Q5What is UTMD's worst drawdown?

Utah Medical Products, Inc. (UTMD) experienced a maximum drawdown of -15.77% over the past year, declining from its peak on 2025-10-02 to its trough on 2025-11-20. The stock recovered to its prior peak by 2026-02-10. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.

Q6What is UTMD's long-term total return over 10, 20, or 30 years?

Here are Utah Medical Products, Inc. (UTMD)'s long-term returns with dividends reinvested. Over 10 years, the total return is 19.1% (1.8% CAGR) — $10,000 would have grown to $11,906. Over 20 years: 183.7% total return (5.4% CAGR) — $10,000 → $28,367. Over 30 years: 475.4% total return (6.0% CAGR) — $10,000 → $57,539. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.

Q7What was UTMD's best and worst year?

Utah Medical Products, Inc.'s best calendar year was 1995 with a total return of 104.4%. Its worst year was 1997 with a total return of -50.0%. This range shows the volatility investors should expect — the difference between the best and worst year is 154.5 percentage points.